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        ABSTRACT 
 
Background: The   association of  periodontitis and  cardiovascular  diseases  is  a  long  
standing  dilemma  and   the underlying   mechanism  between  these  two  diseases  is  
not  clear. Regular  transient  bacteremia occurs  during   tooth brushing  and mastication  
in  periodontitis  patients,  which provoke the synthesis of  proinflammatory  mediators  
in systemic circulation leading to  systemic  inflammation and   platelet activation. 
Consequently coagulation cascade activation leads to atherothrombosis and CVD.  
Aim: This study is aimed to investigate whether periodontitis patients have higher 
platelet activation compared to controls. 
Materials and Methods: About 80 subjects were included and categorized   into control 
group (n=40) and study group (n=40).  This study comprises of a qualitative and a 
quantitative analysis. In qualitative analysis change in shape and aggregation pattern of 
platelets were assessed by spreading analysis test using light microscopy and serum sP- 
selectin level is estimated quantitatively by ELISA method. 
Results :  In present  study    patients  with  periodontitis  showed significantly  higher  
number of  activated platelets and pathological aggregation  pattern  with elevated serum 
sP-selectin level when compared to controls and is positively correlated with the disease 
severity.  
 Conclusion:   Platelet activation is associated with periodontitis and it is severity 
dependent. Chronic persistent low grade systemic inflammation due to periodontitis may 
contribute to cardiovascular disease development and   progression. Chronic periodontitis 
could be a possible risk factor for cardiovascular and cerebro-vascular diseases. 
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                                                 INTRODUCTION 
 Periodontitis is an inflammatory disease of the supportive tissues of the teeth, 
characterized by gradual loss of tooth supporting alveolar bone, and affects up to 10% 
of the population in its most severe form (Pihlstrom BL  2005)91 . The primary 
etiologic factor of  periodontitis is the subgingival infection with a group of Gram-
negative pathogens. The major bacterial species associated with periodontitis are 
Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg) and 
Tannerella forsythia (Tf) (van Winkelhoff AJ, 2002)107 . Inflammation in the 
periodontal tissues  results in areas of ulceration of the epithelium in the   periodontal 
pocket, which leads to dissemination of oral  bacteria into the circulation during 
mastication (Geerts SO,2002)39. Transient bacteremia in periodontitis patients 
underlie chronic production and systemic increases of various proinflammatory  
mediators, including Interleukin (IL)-1, IL-6,  C-reactive protein and Tumor-
necrosis factor (TNF)- . (Loos BG   2005 67; Paraskevas S,2008)8 9 
                 Systemic inflammation   can  cause  increase in the number of platelets and 
platelet  activation (Klinger MH,2002) 63. Activation of platelets leads to the release 
of pro-inflammatory mediators and exposure of pro-inflammatory receptors, resulting 
in platelets binding to leukocytes and endothelial cells. These functions make platelets 
essential participants in both thrombotic and inflammatory reactions across the 
vasculature. (Weyrich AS,2004 ) 113  
           Platelet activation comprises a change in platelet shape, platelet aggregation 
and the release of platelet constituents. Platelet shape change is an early event in the 
activation of  platelets. When platelets adhere to the subendothelial matrix, they  
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change their shape from discoid to spherical with the extrusion of the 
pseudopods.(White JG  1974) 114 
 Also  studies  have  demonstrated  that periodontal  pathogen  like 
P.gingivalis  can activate  blood platelets  and  induce  platelet  aggregation through  
hemagglutinin domain protein  HgP44 .(Naito 2006) 82 
 P- selectin  is  a  member of  selectin  family  of  cell  surface  receptor which  
is located in the membrane of the secretory granules (alpha granules) of  platelets and 
in the membrane of the Weibel–Palade bodies of the vascular endothelial 
cells(McEver RP, 1990)72 . P selectin redistributes from the membrane of the granules 
to the plasma membrane when  platelets and endothelial cells are activated and thus 
degranulated. (Johnston GI,1989) 58   
Platelet activation has been implicated in the development of  atherosclerosis, 
atherothrombosis and subsequent coronary vascular and cerebrovascular diseases 
(Cahill MR,1993)22 . Abnormal platelet activation has also been associated with  deep 
vein thrombosis  (De Boer AC,1981) 30, inflammatory bowel disorders  (Collins CE, 
1994)25 , cancer, peripheral vascular disease, Alzheimer disease ( Sevush S,1998) 101,  
and   atrial fibrillation (Minamino T,1999)78  
Epidemiological and intervention studies have associated periodontitis with 
atherosclerosis and cardiovascular diseases (CVD). The underlying mechanisms of 
this relationship are still obscure (Tonetti MS,2007) 106. 
 Since  only  very  few studies  have  been   documented  regarding association  
of periodontitis  and  platelet  activation  ,  the  present  study  was  undertaken  to  
evaluate   whether periodontitis  patients  have   higher   state of  platelet  activation   
by  estimating  the serum  sP-selectin  expression   and platelet  morphological  




                            AIM  AND  OBJECTIVES 
 
The aim of the present stud y was to invest igate whether  
periodontit is  patients have a  higher state of  plate let  activat ion  
compared  to  healthy  contro ls.  
 
For this purpose, the following objectives were undertaken: 
 
1) To   estimate soluble- P selectin  level  in control and patients  with chronic  
periodontitis    by  ELISA   method. 
 
  2) To  compare  morphological  changes   and   aggregation   of  platelets by   
spreading   analysis  method  using   light    microscope  in  control  and  patients with 





                     REVIEW  OF  LITERATURE  
                          Overview of  platelets 
The normal platelet count is in the range 150–350 x 109/ litre and the platelet 
has a life span of approximately 8–10 days (Bautista AP,1984) 8 . Resting platelets 
are discoid and have a smooth, rippled surface (Felder R,1985) 34 with a diameter 
which averages 1–2 µm and a mean cell volume of around 5–6 fl. Platelets are derived 
from the megakaryocytes in the bone marrow. These megakaryocytes arise by a 
process of differentiation from the haemopoietic stem cell and undergo fragmentation 
of their cytoplasm to produce platelets       ( Avraham H,1993) 5   
The main function of platelets is the formation  of mechanical plugs during the 
normal haemostatic  response to the vessel wall injury, following platelet activation.  
The platelet surface has various receptors and there are diverse stimuli, which activate 
platelets, with equally diverse platelet responses to these stimuli, mediated by the 
binding of various stimulants to specific platelet receptors.  
It is possible to categorize platelet responses into  the ‘reversible’ platelet 
responses, which include adhesion, shape change and reversible aggregation and, the 
‘irreversible’ platelet responses that comprise release reaction and secondary 
irreversible aggregation (Seiss W,1989) 100. Platelet adhesion and a change in shape 
are the initial physiological responses towards the development of haemostatic plug or 
thrombus (Sixma JJ,1991) 104. 
. 





                           
                                           PLATELET  ADHESION 
 
One of the earliest events following blood vessel injury is the adhesion of 
platelets to the areas denuded of  endothelium( Seiss W.1989) 100. A number of unique 
features differentiate  platelet adhesion from other adhesive processes. Platelets bind 
to a variety of extracellular matrix connective tissue components, such as fibrin, 
collagen and laminin (Nurden AT,1993) 83.  
   Platelets also seem to adhere to particulate matter in the blood stream, bacteria 
and other microorganisms, macrophages and the artificial surfaces of prosthetic 
devices  (Packham MA, 1984) 87. This process of platelet adhesion may play a 
fundamentally important role in atherogenesis. 
To provide adequate haemostasis in an injured vessel, platelet adhesion leads 
on to platelet aggregation; thus, activated platelets that are involved in adhesion result 
in further interaction with inactivated platelets in the blood stream. High 
concentrations of integrins and other glycoproteins on the platelet membrane play an 
important role in platelet adhesion to the extracellular matrix. Indeed, the adhesion of 
platelets to the sub-endothelium under flow conditions is well recognized to be 
mediated by a number of proteins in the plasma, of which the more important ones are 
vWF, fibronectin, fibrinogen and thrombospondin (Packham MA,1984) 87. 
         
                                       PLATELET SHAPE CHANGE 
 
   When platelets adhere to the sub-endothelial matrix, they change their shape 
from discoid to spherical with the  extrusion of the pseudopods (White JG. 1974) 114 . 
There is a suggestion that the procoagulant activity and subsequent production of 
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thrombin increases on the platelet surface due to  this platelet shape change (Ehrman 
M,1978) 32. 
    Platelet shape change is influenced by a variety of factors. For   example, it is 
known that platelets could activate and change shape in vitro after venepuncture 
.(Bamber E,1978) 6, following contact with different substances, and by exposure to 
varying temperatures (Watts SE,1986) 112.  
Nachmlas VT  1983 77  found that  most stimuli cause a change in shape .This 
change involves first the formation of very fine (0.1 µm diameter) pseudopodia (i.e., 
filopodia) from the rim of the disc, followed by a general "rounding up" of the platelet 
so that it becomes a spiny sphere, often with much broader pseudopodia.. Importantly, 
a reliable method of differentiating in vivo from in vitro platelet shape change is not 
available at the moment. 
 
                                              PLATELET  AGGREGATION 
The linking of the platelets via fibrinogen brings about platelet aggregation. A 
more number of agents (including ADP, epinephrine, collagen and thrombin) can 
induce platelet aggregation (Kinlough-Rathbone RL,1977) 62. Simplistically, vWF 
and fibrinogen bind to receptors on one platelet and crosslinks to the other platelet by 
binding on to receptors on the latter  ( McManama G,1986) 73 . 
 ‘Reversible’ platelet aggregation is induced by low concentrations of platelet 
stimuli in the presence of extracellular Ca2+ and/or Mg2+, whereas high 
concentrations of the agonists can cause ‘irreversible’ reaction. The latter is the result 
of the platelet release reaction, which relates to the release of arachidonic acid 
metabolites  (Hamberg M,  1974) 42  , especially endoperoxides and thromboxanes, 
and the secretion of platelet constituents from the dense granules (ADP, ATP, 
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serotonin, Ca2+), alpha granules (beta thromboglobulin, Platelet Factor 4, platelet 
derived growth factor etc.) and from the lysosomes (Holmsen H,1969)  48.  
 .  The release reaction, which augments the platelet aggregation, is regulated by 
two positive feedback loops. Firstly, the endoperoxides, thromboxane A2 and ADP, 
which are released during the reaction cause further expression of the fibrinogen 
receptors on the platelet surface by intracellular mechanisms, thus inducing further 
platelet aggregation ( Holmsen 1977) 49.  
Secondly, the synergism between the different platelet agonists augments 
platelet aggregation (Altman R,1986) 2. Full platelet aggregation can also be induced 
by the simultaneous addition of sub-threshold levels of platelet stimuli, which fail to 
induce platelet aggregation on their own merit. Thus, the synergistic action of the 
primary platelet stimulus, other sub-threshold agonist stimuli and the products of 
platelet release reaction build up an efficient  ‘multi-stimulus’ for platelet aggregation. 
Increased  intra-platelet levels of cyclic nucleotides also inhibit platelet aggregation  
(Sakuma I, 1990)95 . These activated platelets contribute to haemostasis and it is 
widely believed that these activities are relevant to thrombosis, especially to arterial 
thrombosis, where the bulk of the occlusion often seems to be due to platelet mass. 
  
                                 Studies  on platelet aggregation 
    
Born 1962 12 observed   that ADP induced aggregation of PLT could be 
demonstrated in citrated platelet rich plasma (cPRP) . This kind of PLT aggregation 
test (PAT I; Breddin 1965) 14, defining different grades of PLT activation 
microscopically, was modified later by Breddin in 197615 (PAT III) using cPRP for 
the performance of a photometrical assay (Breddin 1977) 17. Spontaneous  Platelet 
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aggregation (PAT III) was recorded on a universal aggregometer (Braun, Melsungen) 
using an Eppendorf photometer "1001" by Netheler & Hinz, Hamburg. 
Salzman (1963)96 carried out  microscopic investigation of the filter used  in  
his study showed extensive PLT aggregation on the glass beads. It was concluded that  
the platelet retention by such filters could be  a measure of  platelet  aggregation and 
adhesion. 
Platelet aggregation due to Ca++ dependent processes was also related to 
Platelet  activation by preanalytical circumstances (e.g., time from withdrawal of 
blood to the performance of the assay)  ( Breddin 1974 16, Bauer 1980 ).7     
Breddin 197416 concluded that Platelet aggregation was also attributed to 
inflammatory and atherosclerotic processes . An increased   aggregation may be 
interpreted as a thrombophilic risk variable as demonstrated for either patients with 
arterial diseases  as well as for patients with venous thrombotic diseases. 
Platelet aggregation has been studied by monitoring the changes in the optical 
density of cPRP for PAT III . This assay has been routinely used to evaluate 
hyperactivation of Platelet and can be attributed either to arterial or venous vascular 
diseases.( Breddin 197615 and 1999 )20    
Breddin 198519 ,  1986 18  observed  PAT III  has been proved to be of  
predictive value for new vascular occlusions in diabetics . After the development of 
PAT I (Breddin 1965) 14, several approaches were developed to measure  Platelet 
aggregation other than PAT III e.g., the Wu & Hoak test (Wu 1974 117, Velaskar 
1982)108 using flow cytometric analysis which was of limited value since it was not 
standardized . 
Mc Pherson 1987 74  ,  a vicious circle was hypothesized by which Platelet 
that get   into contact with foreign surfaces are activated (or even damaged), express 
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bioactive amines, stimulating further  Platelet and leading to aggregation and at last 
thrombus formation.  
 
Studies on  Platelet  aggregation associated  with   Periodontitis   
 
Herzberg MC  1983 45  stated  that Streptococcus sanguis is the most prevalent 
species in dental plaque and frequently identified in the polymicrobial bacteremias 
from dental foci.  Platelet aggregating  strains (Agg+) of S. sanguis induce 
aggregation of human platelets in vitro. This phenomenon is mediated by the 
expression of the platelet aggregation-associated protein (PAAP) on the surface of 
certain strains.  
In 1989,  Mattila KJ 70   stated  that dental infections may also contribute to  
the risk of atherosclerosis and MI. 
 Gingipain-K from P. gingivalis interferes with the blood-clotting system by 
human platelet aggregation.  P. gingivalis cleaving both fibrinogen and kininogen to 
release the vasoactive peptide, bradykinin. (Scott CF,1992 ). 99  
Herzberg MC 199446 observed that Streptococcus sanguis, the predominant 
microorganism found in bacteremias   following toothbrushing or dental procedures, 
and P. gingivalis, an invasive periodontal pathogen, also induce platelet aggregation 
In  the same year  Steiner M et al 105, stated that S. sanguis may also induce 
thromboembolic events. The Aggregation (Agg+) phenotype may be associated with 
the occurrence of disseminated intravascular coagulation- like syndrome in immune-




Beck 1996 9 postulated that the association between severity of periodontal 
disease and the risk of CHD may be due to the biologic burden of  Gram-negative 
infection and the inflammmatory mediators  of periodontal disease. 
Zambon 1997 118 observed that atherosclerotic plaques are commonly infected 
with Gram-negative periodontal pathogens, including A. actinomycetemcomitans and  
Porphyromonas gingivalis. 
 
Pham, 1998 90 was first to demonstrate that the membrane vesicles were also 
potent activators of human platelets, and that purified gingipain-R from the membrane 
vesicles caused this activity. This is an important finding in that it lends support to the 
concept that shedding of these membrane vesicles may be an important virulence 
factor not only in inflammation but also in micro thrombus formation in humans. 
Herzberg MC1994 46  hypothesized that Agg+ S. sanguis is thrombogenic; 
experimental bacteremias in rabbits would cause thrombosis and acute changes in 
cardiopulmonary function. Intravenous  infusion of 4 X 10s colony forming units 
(CFUs) of S. sanguis 133-79 (Agg+) causes a  rise in blood pressure within the first 
minute. Infusion of an Agg" strain or saline was without effect. The Agg+ strain 
caused dose dependent changes in blood pressure, heart rate, and the percentage of 
rabbits showing  increased cardiac contractility. 
Sharma et al  2000 102  have shown that P. gingivalis membrane vesicles 
aggregate murine platelets. 
 
Lourbakos et al.2001 69 reported  that two forms of purified gingipain-R, the 
50- kDa  RgpB and  the 95-kDa RgpA, caused aggregation of human platelets  with 
efficiency comparable with thrombin, by a mechanism involving cleavage of the 
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protease-activated receptors (PAR)-1 and –4, expressed on the surface of  platelets. 
purified gingipain-R which aggregated platelets at 0.01 mg/ml or 0.1 nM. 
Li et al.2002  65 reported  that mouse model of atherosclerosis using 
apolipoprotein E-deficient mice, intravenous and oral inoculations of  P. gingivalis  
cells were found to accelerate atherogenic plaque progression  and to enhance 
vascular activation (Lalla et al., 2003)  6 4 respectively. 
 
                                         P-SELECTIN: Structure  and   function   
P-selectin (CD62P, previously also known as GMP- 140 and PADGEM) is, 
alongside E-selectin (CD62E)  and L-selectin (CD62L), a member of the selectin 
family of adhesion molecules, sharing common structural features but having 
different tissue distributions. It has a mass of approximately 140 kDa and is a protein 
rich in cysteine, containing several complex    N-linked  oligosaccharides chains. The 
extracellular domain is arranged as a lectin region (the amino-terminal of 120   amino 
acid residues), an epidermal growth factor-like  region and nine discrete complement 
regulatory-like regions (each about 60 amino acid residues in length). In addition, 
there is a cross-membrane  segment and an  intra-cytoplasmic tail . 
P-selectin is so named  because it is a component of the cell membrane of the 
 granules of platelets, the organelle which stores coagulation- related substances 
such as  - thromboglobulin and platelet factor 4. It is also a component of the 
membrane of the Weibel-Palade body (the endothelial cell specific organelle which 
stores von Willebrand factor) and is rapidly mobilised to the cell surface by various 
stimuli including inflammatory mediators (Bevilacqva  1993 10 & Wagner 1993 )110 
The mucin-like glycoprotein ligand for P-selectin (PSGL-1) bears O- and N-
linked carbohydrates, and is found on neutrophils, Natural Killer cells, monocytes and 
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T-lymphocytes, giving rise to the hypothesis that it is involved in an interaction 
between these leukocytes and the endothelium, (possibly as part of the rolling: 
binding:activation sequence), between platelets and neutrophils, and between platelets 
and the endothelium( Geng 1990) 40 
 
Hattori 1989 44  reported   that in cultured endothelial cells, membrane 
expression of P-selectin can be induced with inflammatory mediators such as 
thrombin, lipopolysaccharide, tumour necrosis factor, oxygen radicals, complement 
components and  histamine. Therefore it may be that this increased surface  
expression is a further marker of activation. However, it is likely that this expression 
is transient and that it is endocytosed within a period   of up to 4 hr, possibly to be 
recycled for further use. It is strongly expressed by endothelium overlying fibro-fatty 
and complex atherosclerotic plaques, weakly on endothelium overlying fibrous 
atherosclerotic plaques and is absent from normal arterial endothelium ( Johnson -
Tidey  1994).57 
McEver RP  1989 71 stated  that P-selectin is a membrane constituent of both 
platelet  granules and endothelial cell Weibel-Palade bodies, soluble levels can be 
derived from either source. 
Hamburger 1990 43 found  that   thrombin will also induce increased surface 
expression  of     P-selectin on platelets for up to 1 hr, a finding that leads to the 
conclusion that increased cell membrane expression of P-selectin is a marker of 
stimulated or activated platelets . This may find clinical value as platelet P-selectin 




The role of  P-selectin could be twofold: first, it might inhibit excessive 
leukocyte recruitment by inhibiting leukocyte adhesion to the endothelium as was 
shown with purified platelet P-selectin and downregulate neutrophil activation; 
second, it could inhibit resting platelet rolling on P-selectin and thus prevent 
excessive platelet recruitment to the growing platelet thrombus.( Gamble JR,1990)38 
Dunlop LC 1992  31  stated  that soluble P-selectin is found at concentrations 
of about    0.1 to 0.2 µg/mL  in human plasma. 
        Increased levels of soluble P-selectin have been described in diseases such as 
ischemic stroke, atherosclerosis, hypertension, thrombotic thrombopenic purpura, 
eclampsia, thromboembolic diseases, malaria, and diabetes as well as in different 
stages during the menstrual cycle of healthy women.( Katayama M 1993).60 
Chong BH,1994 24 concluded  that failure of levels of soluble P-selectin to 
correlate with an established marker of platelet activity, - thromboglobulin, implies 
that it is related to a different aspect of platelet activation or physiology. 
Michelson AD,1999 77  concluded  that  failure of levels of soluble P-selectin 
to correlate   with an established  endothelial cell marker (von Willebrand factor) , 
implies that soluble P-selectin is derived from platelets. This is supported by 
preliminary flow cytometry experiments in non-human primates  which indicate that a 
loss of surface membrane P-selectin from platelets is accompanied by an increase in 
soluble P-selectin . 
           Administration of desmopressin (an agent which will induce the degranulation 
of the Weibel- Palade body) to healthy males increases levels of plasma von 
Willebrand factor but does not influence levels of soluble P-selectin . These data 
suggest that it is likely that soluble   P-selectin is not the product of the endothelium.  
( Jilma B,1996) 55 
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Blann AD,1997 11 compared of levels of circulating protein markers of 
endothelial cell or platelet activation with that of soluble P-selectin have suggested 
that activated platelets were the major source of the excess of soluble P-selectin and 
hypothesized  that soluble P-selectin has potential as a new marker of platelet 
activation.    
               P-selectin expressed on activated platelets causes formation of platelet-
neutrophil (Ott I,1996)85 and  platelet-monocyte aggregates in blood.(Rinder 
HM,1991)93 . Platelet  microparticles, containing P-selectin, were also shown to 
support leukocyte-leukocyte interaction under flow (Forlow SB,2000)35 .These 
associations could augment infiltration of monocytes into atherosclerotic 
lesions,similar to L-selectin promoting secondary capture of leukocytes at sites of 
inflammation.( Eriksson EE,2001)33 
Ikeda H, 1999 52  have  demonstrated by immunohistochemical analysis the 
incorporation of platelets with upregulated P-selectin to leukocytes in large arterial 
thrombi of a canine model of acute coronary syndromes . Also  hypothesized that P-
selectin plays an important role in arterial thrombogenesis by forming large stable 
platelet-leukocytes aggregates. 
Platelet derived microparticles associated with PSGL-1–expressing 
hematopoietic stem cells and facilitate their homing to the bone marrow. By a similar 
mechanism, P-selectin on microparticles could coat monocytes and contribute to their 
recruitment into atherosclerotic lesions. Interestingly, monocytoid cells were shown to 
roll and adhere to endothelium in vitro at a much higher shear rate when complexed 
with activated platelets than alone. This could help homing of the monocytes in 
unfavorable shear stress conditions.( Janowska-Wieczorek A, 2001 ) 54 
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               Platelets and platelet microparticles were shown to deposit chemokines, such 
as RANTES (Von Hundelshausen P, 2001)109  or other agents,on endothelium, which 
can attract and activate monocytes, thus possibly promoting their recruitment into the 
atherotic  lesions.  Platelets or substances   released from activated platelets were 
shown to induce in vitro macrophage foam cell formation and thereby could 
contribute to lesion growth.( Curtiss LK,1987)28 
Molenaar TJM.  2003 79  quantitated the expression of endothelial P-selectin 
levels in apoE_/_ mice by real-time PCR, and compared its tissue specific expression 
with that of VCAM-1,  CAM-1 and E-selectin. Results  showed  P-selectin mRNA 
expression  increases 14  fold induction was observed as compared with control mice   
suggesting that P-selectin is a good candidate for intervention, progression of lesion 
formation,  lesion imaging, or targeting strategies. Furthermore, selective P-selectin 
antagonists by using phage display technology, such ligands may be useful in the 
future to identify, target or antagonize P-selectin during atherosclerosis. 
Papapanagiotou 2009 88 compared P-selectin  expression in control and  
periodontitis  patients  and  concluded  that  periodontitis is associated with increased 
platelet activation  and  via platelet activation, periodontitis may constitute a risk 
factor  for CVD.  
     Assinger.A  2010 4 study  indicated that stimulation with periodontopathogens 
results in surface expression of P-selectin in both platelets and endothelial cells within 
minutes. Therefore, both cell types seem to be responsible for the observed increased 
plasma levels of soluble P-selectin in periodontitis. 
 




 MATERIALS  AND METHODS 
 
STUDY  DESIGN  AND  SUBJECT SELECTION: 
 
The   study was   approved  by  the  Institutional  Ethical committee. About 80  
patients  in  the  age   group  of  35- 60  years who  attended  the  out patient 
department , Department of Periodontics, Tamilnadu Government Dental 
College,Chennai  between  June  and  October 2010  participated  in the  study .  the 
patients  were divided  into  2  groups,  40 subjects  with  generalized chronic 
periodontitis   and  40 healthy subjects    taken  as   control. 
A   written informed  consent  was  obtained  from  all   patients.    A complete 
history  and  clinical  features  of  the  subjects    attending study  were obtained. Prior  
to  blood  sample  collection , plaque  index, bleeding index, probing  depth,  clinical  
attachment  loss  were  recored. 
 About  10ml of  venous  blood samples  were  collected  from  the  patients 
with  or without  periodontitis  for  ELISA  and  spreading  analysis  test. 
INCLUSION CRITERIA:        
1.  Patients willing for voluntary participation and signing the informed 
consent. 
2. Age : 35-60 years  
3. Gender : Both males and females 
4. Patients with  generalized chronic periodontitis  with minimum  20 teeth. 
   
 EXCLUSION CRITERIA: 
1.  Trauma or  tooth  extraction  within 2 weeks 
            2.  Patients  drug  history(  antibiotics, anticoagulants)  for  past 2  months. 
            3.  Any  chronic   infectious diseases. 
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            4.   Pregnancy  
            5.  Anemia, bleeding disorders or any other hematological disorder  
            6.  Cardiac diseases  
            7.  Stroke 
            8.  Habits  like  smoking , pan chewing, alcohol. 
 
The selected  patients were  divided into two groups (Control and Study groups) 
based on the following criteria: 
 
Control Group: 
This included 40  healthy  subjects   who exhibited  the following features: 
  No Bleeding on Probing  
 Absence of Clinical Attachment loss as determined by CAL (Clinical 
Attachment Level) measurements i.e. CAL=0. 
 Good  oral   hygienic  status 
Study Group: 
The diagnosis of Chronic Periodontitis was established on the basis of   
Classification of  Periodontal  Diseases, AAP 1999. 
 Bleeding on Probing 
 Probing pocket  depth  in mm 
 Presence of signs of Clinical Attachment Loss as determined by CAL 
measurements ≥ 5mm. 
 At least   a minimum 20 teeth were  should  be  present. 





1  Institutional  ethical  committee  approval   
2.  Medical History and Informed Consent 
3. Periodontal Examination using clinical parameters namely, Bleeding Index, 
Plaque Index, Probing Pocket Depth and Clinical Attachment Level. 
4. Collection  of blood samples 
5.  Estimation   of  serum soluble  P- selectin  level  by  ELISA  method. 
6. Evaluate the   Platelet  morphology  and   grading  the  platelet aggregation. 
      Following selection of subjects, written informed consent was obtained from 
all the subjects selected for the study after explaining the study procedure. 
Examination was preceded by a thorough medical and dental history of the subjects. 
Intra-oral examination was done using mouth mirror and William’s Periodontal 
Probe. Periodontal Evaluation was done by measuring the Bleeding Index, Plaque 
Index, Probing Pocket Depth (PPD) and Clinical Attachment Level (CAL) 
CLINICAL PARAMETERS 
 GINGIVAL BLEEDING INDEX (Ainamo & Bay 1975)1 
Teeth examined - All teeth 
Surfaces examined - 6 sites for each tooth (Mesiobuccal,Midbuccal,                                         
Distobuccal, Mesiolingual, Midlingual and Distolingual) 
The presence or absence of bleeding is determined by gentle probing of the gingival 
crevice with a periodontal probe. 
Criteria for Scoring 
Positive score (+) - Presence of bleeding within 10 seconds  
Negative score (-) - Absence of bleeding 
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    Total number of positive score 
% of bleeding sites =            x 100 
    Total number of surfaces of all teeth 
PLAQUE INDEX  (Silness and Loe 1964)23 
Teeth examined – All teeth 
Surfaces examined – 4 sites for each tooth (disto-facial, Facial, Mesio-facial, 
lingual/palatal)  
Criteria for Scoring: 
Score 0 No plaque 
Score 1 Plaque not visible to the naked eye, detected by explorer 
Score 2 Thin to moderate accumulation of soft deposits within the gingival 
pocket or on tooth, visible to the naked eye 
Score 3 Abundance of soft matter within gingival pocket or on tooth surface 
and margin, inter-dental area stuffed with soft debris 
 
Calculation : Plaque  index  for  a  tooth= total  score  from  4  areas/4 
Plaque index for the individual = Total Plaque indices for all teeth / No. of teeth 
examined .                                
Interpretation:   Score   0 – Excellent oral hygiene 
                           0.1 to 0.9 – Good oral hygiene 
                           1.0 to 1.9 – Fair oral hygiene 




PROBING POCKET DEPTH (PPD) (Grant 1965)4 1  
Probing Pocket Depth was measured from the gingival margin to the base of 
the pocket using William’s Periodontal Probe. The probe was passed within the 
gingival sulcus along the circumference of the tooth.  
Three measurements were made on the buccal aspect and three on the lingual 
aspect of each tooth – total of six sites per tooth (Mesiobuccal, Midbuccal, 
Distobuccal, Mesiolingual, Midlingual, Distolingual). 
 
CLINICAL ATTACHMENT LEVEL (CAL) ( Carranza)23 
Clinical Attachment Level was measured from the Cemento – Enamel Junction 
(CEJ) to the base of the pocket using William’s Periodontal Probe.  
 When the gingival margin was located on the anatomic crown, the level of the 
attachment was determined by subtracting from the probing pocket depth, the 
distance from the gingival margin to the CEJ. If both were the same, the loss 
of attachment was calculated to be zero.  
 When the gingival margin coincided with the CEJ, the loss of attachment was 
calculated as equaling the probing pocket depth.  
 When the gingival margin was located apical to the CEJ, the loss of 
attachment was greater than the probing pocket depth and therefore the 
distance between the CEJ and the gingival margin were added to the PPD. 
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Three measurements were made on the buccal aspect and three on the lingual aspect 
of each tooth – total of six sites per tooth (Mesiobuccal, Midbuccal, Distobuccal, 
Mesiolingual, Midlingual, and Distolingual). 
Armamentarium: 
Mouth mirror 
William’s  periodontal  probe 
Head cap 
Gloves and  mask. 
 
BLOOD  SAMPLE  COLLECTION AND STORAGE:  
Fasting venous blood samples   about  10ml  was  collected  without stasis 
using 20G needle by venipuncture in the antecubital fossa  after  skin  preparation. 
About  5ml of  blood is allowed  to  stand in plain vacutainer  tube   for  30 min   to  
separate  the  serum  and centrifuged  at 3000 rpm for  10 min.  Then  500l  of  
serum sample was divided in aliquots and stored at  -20C  until analysis. 
          Remaining  5 ml of blood is divided  into  2 parts. About  4ml  of  blood 
immediately  transferred  into 3.8% sodium  citrate solution containing vacutainer 
tubes  for   PRP  preparation, and  about  1ml of  blood  transferred into EDTA 
containing vacutainer tubes  and    used  for whole  blood  analysis. 
PROCEDURE: 
I.  ELISA METHOD:   
A soluble form of P-selectin, which might represent a proteolytic fragment or 
a soluble splice variant lacking the trans membrane domain, is found in serum  which  
is  estimated  by Diaclone ELISA  Kit, France. 
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Contents  of  test kit: 
1. 96-wells microtiter plates:  Ready-to-use 
2. Standard: 140 ng/ml, 2 vials , 
      Reconstituted with the volume of standard diluent indicated on the vial.  
3.  Standard Diluent Buffer: 1 vial  
25 ml dilute 10 times in distilled water 
4. Biotinylated anti-CD62P  : 1 vial ,Dilute in biotinylated antibody diluents 
5. Biotinylated Antibody Diluent: 1 vial (7ml)  
     Ready-to-use 
6.  Streptavidin- HRP : 2 vials  
           0.5ml of HRP-Diluent before further dilutions 
7.  HRP Diluent :  1 vial  (23 ml) 
           Ready-to-use 
8.  Washing Buffer : 1 vial (10 ml) 200X concentrate.  
         Dilute in distilled Water 
9.  Chromogen TMB : 1 vial (11 ml) ; Ready-to-use 
10. H2SO4: Stop Reagent  ,1 vial  




Eppandorf  tubes 
Plastic rack 




Autoclaved  plastic tips 
Micropipette  
ELISA  washer 
ELISA   reader 
 
ASSAY METHOD 
i. Before use, all reagents are mixed thoroughly without making foam. 
ii. Number of micro wells strips required to test the desired number of samples, 
plus appropriate number of wells needed for running blanks and standards  are  
determined. Each sample, standard and blank should be assayed in duplicate .  
iii. About 100 µl of standard diluents is added to standard wells B1, B2, C1, C2, 
D1, D2, E1, E2, F1, F2. Reconstitute the standard vial with the appropriate 
volume .Pipet 200 µl of standard into wells A1 and A2 .About 100 µl 
transferred  from A1 and A2 to B1 and B2 wells. Contents are  mixed  by 
repeated aspirations and ejections. Taking care not to scratch the inner surface 
of microwells. The procedure  is repeated  from the wells B1, B2 to wells C1, 
C2 and  from wells C1, C2 to D1, D2 and to create two parallel rows of 
CD62P standard dilutions ranging from 140 to 4.4 ng/ml.  100 µl from the 
content of the last microwells used (F1, F2) was  discarded.  
iv. Alternatively these dilutions can be done in separate tube and the diluted 
standard pipetted directly into wells. 
v. About 100 µl of standard diluent   is  added to the blank wells (G1-G2). 
vi. About 100 µl of  serum sample  was  added to sample wells. 
vii. The plate   is covered and incubated for 1 hour at temperature (18°C - 25°C). 
viii. T he cover is   removed and washed in  the plate following  manner: 
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a. The liquid from each well is aspirated  
b. About 0.3 ml of washing solution  is  added  into each well ; 
c. The content of each well was aspirated again 
d. steps a) and b) are  repeated   two times. 
ix. Biotinylated anti-CD62P  solution  prepared. 
x. About 50 µl of diluted biotinylated anti-CD62P   was added to all wells. 
xi. Covered  and incubated  for 1 hour at room temperature. 
xii. Washed as described   at step viii 
xiii.   HRP solution prepared  just  before to use . 100 µl of HRP solution is 
dispensed into all wells, including the blank wells. The cover  was put back 
xiv. The microwell strips   were incubated at room temperature for 30 minutes. 
xv. The  plate  cover was  removed and wells emptied .The microwell strips  
washed  as per step viii  
xvi. About 100 µl of ready-to-use TMB substrate solutionwas  added into all wells, 
including the blank wells and incubated  in the dark for 5-15 min minutes at 
room temperature. Avoiding direct exposure to light by wrapping the plate in 
aluminium foil. Incubation time of the substrate solution is usually determined 
by the ELISA reader performances: many ELISA readers record absorbance 
only up to 2.0 O.D. The O.D. values of the plate should be monitored and the 
substrate reaction stopped before positive  wells are no longer properly 
readable. 
xvii. The enzyme-substrate reaction is stopped by quickly pipetting 100 µl of 
H2SO4: stop reagent into each well, including the blank wells, to completely 
and uniformly inactivate the enzyme. Results were read immediately after the 
addition of H2SO4: stop reagent. 
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xviii. The absorbance of each well  was read  on a spectrophotometer using 450 nm 
wavelength. . 
                
                       ASSAY PROCEDURE SUMMARY 
                 
                        About 100µl of sample added. 
                                               ⇓ 
               Incubated  for 1 hour at room temperature 
                                               ⇓ 
                                 Washed three times 
                                               ⇓ 
              About 50 µl of biotinylated detection antibody  added 
                                               ⇓ 
               Incubated  for  1 hour at room temperature 
                                               ⇓ 
                                  Washed three times 
                                               ⇓ 
             About 100 µl of Streptavidin-HRP added 
                                               ⇓ 
               Incubated   for 30 min at room temperature 
                                               ⇓ 
                                  Washed three times 
                                               ⇓ 
                 About 100 µl of ready-to-use TMB added 
               (Protect from light. Let the color develop for 5-15 min) 
                                               ⇓ 
                                   Added 100 H2SO4   (stop  reagent) 
                                               ⇓ 
                                 Read Absorbance at 450 nm 
 
 
Calculation of results: The optical  density  of  each sample  was  plotted   against  






II. SPREADING  ANALYSIS  TEST: 
This test was adapted from the method introduced by Marx 1960 and modified by 
Breddin 1965.14 
 
Preparation of citrated platelet rich plasma (cPRP) 
About 4ml was blood  drawn and transferred  into vacutainer tube  mixed  
with sodium citrate  in  1: 9 ratio. Then sample was  centrifuged at 2000 rpm for 
15min without break at room temperature. The resulted cPRP was transferred 
carefully by micro-pipette (using new disposable plastic tips) into a plastic collection 
tube to get ready for further analysis. The  aspiration of the cPRP was performed with 
a specific care not to disturb the lower layers of leukocytes   and erythrocytes. The 
cPRP was pipetted gently on the inner wall of the collection tube. 
 
REAGENTS  USED : 
1.Sodium citrate solution :  0.3% solution  used for lowering the  viscosity of the 
blood reactions.  
2. Formaldehyde solution 11% : One liter (i.e., 1.04 kg) stock solution for analysis 
stabilized with 10% methanol (toxic); 
3. Potassium permanganate solution 0.1% N: 3.161 g KMnO4/ 100 mL; and stored 
in dark place. 






Plastic  slides (75mmx 25mm) 
Micropipette  
Plastic  tips 




             Platelet counts was assessed with a  Sysmex  Automated  Haematology  
Analyzer KX-21  and  each  PRP  samples was adjusted  to  0.3 ×108/ml with 0.3% 
sodium citrate. 
     1. About 2-4 mL of the resultant platelet suspension is poured on a specific 
athrombogenic   plastic slide   and incubated at room temperature for 30 min allowing 
the platelets to  adhere and spread on the slide. 
   2. The slide was rinsed carefully with the isotonic Na-citrate solution  
   3. Fixation step: The  slide  was  allowed  to  stand in 10% formaldehyde solution  
for 7  mins. 
   4. The slide is rinsed with isotonic Na-citrate solution. 
   5. Oxidation step: The slide was allowed to  stand  in the 0.1N potassium 
permanganate solution  for 5 mins. 
   6. The slide was  rinsed with isotonic Na-citrate solution. 
   7. Staining is accomplished by  using Giemsa’s solution  for  60 mins. 
   8. The slide  was rinsed gently with distilled  water  and  air dried. 





Platelet  size  and  morphology: 
The preparations of Platelet spreading were examined by light microscopy.  
According to Scharrer 1985 97, five types of PLT can be distinguished in  healthy 
individuals:  
 
(1) Giant forms with a surface of more than 200 µm. 
 (2) Big forms with minimum one diameter more than 10 µm.  
(3) Small forms with an average diameter less than 10 µm. 
 (4) Intermediate forms (round, etc.,) which are not completely spread and have little 
hyalomere between pseudopodia. 
(5) Spider forms which are not spread Platelet with one or more short and relative 
thick pseudopodia.  
The    forms 1-3 are defined as spread  Platelet forms while the forms 4 and 5 are not 
spread. In   this study ,  we  examined  only  big , small  and spider  forms for  
percentage  calculation.   
During microscopic examination, hundred Platelet were counted in each 
Platelet  spreading preparation. The findings were recorded on an application that was 
designed to include the complete   descriptions of the examined preparations as 
follows: 
A.) The technical quality of the preparation (thickness, coloring, dirts if any, etc.) was 
differentiated. The thickness of the preparations reflect firstly the Platelet count of the 
tested sample and secondly the adhesion of  Platelet. 
B.) The relative presence in percentages (%) of the spread (big, and small) and non-
spread ( spiders). 
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C.) The grades of Platelet aggregates (Aggr) were assessed semi quantitatively, and 
differentiated according to grading system given by Breddin HK, Bauke J 1965.14 
 
Platelets aggregation grading: 
In this test, reversible platelet aggregation means the sticking of platelets to 
each other without fusion, with their membranes intact. In irreversible aggregation, 
platelets are fused and membranes are partly destroyed. The platelet aggregation is 
graded according to the following characteristics: 
 Grade 1: Platelets are seen single with only a few reversible aggregates and 
no irreversible aggregates. 
 Grade 2: More reversible aggregates are found, but there are no or only very 
few irreversible aggregates; there is no obvious reduction in single platelets.  
 Grade 3: An increase in reversible aggregates is evident, often with 
irreversible aggregation at the centre; the number of platelet is clearly 
diminished. 
 Grade 4: There are  more irreversible than reversible aggregates; single  
platelets are rare.  
 Grade 5: There is complete  irreversible aggregation; single platelets are 
practically missing. 
 The grades 1 and 2 after rotation were taken as normal, and the grades 3, 4, and 5 
as pathological aggregability. 
WHOLE  BLOOD ANALYSIS: Citrated  blood was used  for whole  blood  
analysis by  using Sysmex  Automated  Haematology  Analyzer . Total WBC, 




                                         
                   Photograph No: 1   Healthy control group    





                       





                  




                    







                       




                                 
                         
                          Photograph No. 6  Collection of blood sample 
                           
                           





                                                     






   
Photograph No.8   Deep freezer  and  samples  stored at -20 0C 





   
 
 
                   
   Photograph No.9   ELISA  KIT & its contents 
 




       
Photograph No.10  96well  microplate of  ELISA KIT and micropipettes  &tips 
 








                     




   





 STATISTICAL    ANALYSIS 
The statistical analysis  was  done using  the computer  software  program 
SPSS  version 12. 
Mean and Standard Deviation were estimated for different variables in each study group.  
Mean values were compared between two study groups by using either Student’s 
Independent t-test or Mann-Whitney U-Test.  
Pearson’s chi-square test was done to compare the proportions   in two study groups.  
 In the p resent stud y, P-value <0.05  was considered  as the level 
of significance .        
 
Statistical Formulae Used For Data Analysis 
Pearson’s Chi-square Test 
  The formula used was  
 
Where O = Observed frequency in a cell 







The formula is 
 
Where n1 and n2 are the sample sizes in Group I and Group II respectively.  
T is the sum of the ranks for the n1 observations. 
Student’s Independent t-test 
 
The formula used is  
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                           RESULTS 
Eight y subjects were included in the present  study. The subjects 
were categor ized into two groups – cases (n = 40) and contro ls (n = 
40). 
Table I& II  shows the  master chart  of  study and  control group with 
the  var iab les,  clinical parameters  and  tests done  in both  groups  in  
the  study.  
Table III    shows the comparison of age between study and control 
groups.  There is no stat ist ica l difference in the distr ibu tion of sex in 
both the groups.   
Table IV shows  the comparison of gend er distr ibution between study 
and control group. There is no statist ica l difference in the distr ibution 
of gender in both groups. 
Table V  shows the comparison of mean PPD & CAL(mm)  of control  
and study  group.  The mean PPD value of control group is 2.11mm and of study 
group  is about 4.9mm and the mean CAL value of cases 5.8mm. 
Table VI & Figure I  shows mean number   of   total  WBC, RBC,&  Hb %  for  
control  and  study  group.  WBC counts in study group( 8.04± 1.84 x 103)in contrast 
to the control group (5.46±1.84 x 1.23 x 103) with statiscal  significance.(P <0.001). 
          Mean value of RBC count (control 3.99 ± 0.58 x 106 study group 4.41 ± 
0.51 x 106)  with P-value 0.001and Hb% (control 11.43 ± 1.32 gm % study group 
12.20 ± 1.87 gm% with P-value 0.035) .Statiscally  the  mean value  of  RBC  count, 
Hb %   among   control  and  study  group  is significant.  
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Table VII& Figure II and III  shows  that the mean Platelets, Neutrophils, 
lymphocytes count. In  study  group mean  platelet  count was found to be 281.25 ± 
84.5 and the control  group is about 200.98 ± 56.9  which found to be statistically  
highly significant (P=<0.001). 
       Mean value of neutrophil count  in control   group 2.94 ± 0.68 x 103& study 
group 4.09 ± 1.50 x 103 ) and lymphocyte  count  in  control 1.95 ± 0.55 x 103 & study 
group 2.83 ± 0.72 x 103) . It was found to be statiscally highly significant (P<0.001)  
among   the  study  group 
Table  VIII  & Figure IV  shows   mean P-selectin   expression   in both  control  and  
study   group. Statistical  analysis shows that the mean value for control group is 4.97 
± 16.56 ng / mL and study group 13.05 ± 29.94 ng / mL  which  was  significantly  
higher than control  group with  P-value 0.001.  
Table  IX & Figure V  shows  Pearson’s   correlation  of  P- selectin  expression   
and  mean   CAL   level  of controls  and  cases. Result  shows  that increased   P-
selectin   expression is  positively   associated  with  CAL  level .(P-  value < 0.001). 
Table X  and  Figure VI &VII  shows  platelet  morphological  changes in  control  
and study group. Small form – mean value for control group  is 75.83% ± 14.24% 
while for study group is 39.08 %. ± 21.59 ;Big form – mean value for control group 
0.80%  ± .35% while for study group  0.48% ±   1.3%and Spider form- mean  value 
for control group 23.88% ±14.13 while study  group 59.32% ±.   23.42 .The 
observation showed  high  statistical   significance with  P- value  <0.001  for  small  
and  spider  form and  no  statistical significance  for  big  form P =0.075. 
Table XI  & Figure VIII    shows distribution of platelet  aggregation   grading  for   
control  and   study group . Grade I in control group shows 77.8% and study group 
shows 22.2%.Grade II – control group 75.5% and study group 24.3%  ; Grade III -
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control group 15.6% and study group 84.4%; Grade IV – control group 0% and 
100% for study group. 
   Within the group correlation showed grade II (70%) found maximum among 
the control group followed by grade I (17.5%) Grade III (12.5%) and grade IV (0%) . 
For study group grade III (67.5%) was found to be maximum followed by grade II 
(22.3%) and grade I & grade IV (5.0% each) with P-value <0.001. 
Table XII & Figure IX   shows that   correlation between P-selectin expression   and 
platelet  aggregation  grading. Pearson’s  correlation   shows a  positive correlation   
between   these   two  variables with  the  P-value 0.005  among  the  study  and  















 TABLE –III : COMPARISON  OF AGE  BETWEEN CONTROL & STUDY GROUP 
 
  Group N Mean 
Std. 
Deviation P-value 
Age in  
years 
Control 40 42.23 7.123 0.589 
(NS) 
  Study 40 43.20 8.106 
 
 







  Group Total P- value 









Sex Male Count 17 19 36 




    % within 
Group 
42.5% 47.5% 45.0% 
  Female Count 23 21 44 
    % within 
Sex 52.3% 47.7% 
100.0
% 
    % within 
Group 57.5% 52.5% 55.0% 
 
 
           Total 
  
  
Count 40 40 80 
% within 









TABLE V:  MEAN PROBING DEPTH AND CAL  OF CONTROL & STUDY  GROUP 
 Group N Mean 
Std. 
Deviation P-value 
PPD in mm Control 40 2.1160 .19013 0.000 
  Study 40 4.9960 1.09803 0.000 













  Study 40 5.8080 1.10563 0.000 
 
 
TABLE-VI : COMPARISON OF WBC,RBC,& Hb. BETWEEN CONTROL &  STUDY  
GROUP   
 
 





Control 40 5.460 1.2345 <0.001** 
(SIG) Study 40 8.037 1.8352 
RBC 
  
Control 40 3.9925 .57687 <0.001** 
(SIG) Study 40 4.4128 .50902 
HB 
  
Control 40 11.425 1.3210 
0.035* 









TABLE –VII: COMPARISON OF PLATELETS, LYMPHOCYTES,NEUTROPHIL  
COUNTS  BETWEEN CONTROL & STUDY  GROUP     
 
  Group N Mean 
Std. 
Deviation P-Value 
No. of Platelet Control 40 200.98 56.914 
<0.001 
  Study 40 281.25 84.543 
Lymphocyte Control 40 1.948 .5547 
<0.001 
  Study 40 2.825 .7221 
Neutrophil Control 40 2.940 .6778 
<0.001 







COMPARISON  OF P- SELECTIN  IN  CONTROL AND STUDY  GROUP 
 
 Group N Mean 
Std. 
Deviation P- value 
P-Selectin Control 40 4.97 16.558 0.001** 









TABLE  IX : COMPARISON OF P-SELECTIN  EXPRESSION TO  SEVERITY OF  
CAL    IN  STUDY  GROUP 
   
P-
Selectin 
CAL in mm 
 
     control 
Pearson 
Correlation         .(a) 
Sig. (2-tailed)             . 
N           40 
CAL in mm 
      Study 
Pearson 
Correlation .608(**) 
Sig. (2-tailed) .000 
N 40 
**  Correlation is significant at the 0.01 level (2-tailed). 
 
TABLE – X:  COMPARISON OF PLATELET MORPHOLOGY OF CONTROL & 
STUDY GROUP 
 
  Group N Mean 
Std. 




Control 40 75.83 14.240 <0.001** 
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TABLE  XII: CORRELATION  OF  sP- SELECTIN  LEVEL  AND  PLATELET  
AGGREGATION GRADING 







  Sig. (2-tailed) . .005(Sig) 
  N 80 80 





Correlation .309(**) 1 
  Sig. (2-tailed) .005 (Sig) . 

















FIGURE I: COMPARISON   OF  WBC ,RBC & Hb% IN  CONTROL &  STUDY  




FIGURE II : COMPARISON OF  LYMPHOCYTES, NEUTROPHIL  COUNTS  IN 






































FIGURE III: COMPARISON OF  PLATELETS COUNTS IN  CONTROL &STUDY 











































FIGURE V: COMPARISON  OF  SEVERITY OF PERIODONTITIS  WITH               

























































STUDY   GROUP
55 
  
FIGURE VIII : PLATELET AGGREGATION GRADING  DISTRIBUTION  IN 






















































                                               






                        
 






                                                                             








                      








Photograph No :17  shows  higher   magnification of of  Spider  forms   platelets 
 
             




Photograph No :19  Irreversible  platelet  aggregetion   with  ruptured membrane          





          
Photograph No :20  Irreversible   aggregation pattern  (pathological  aggregation) 
 






Photograph No :21     Larger  irreversible   aggregation pattern  in  study  group 






Periodontal  d isease  ma y be   related   to  a number  of systemic  
diseases  inc luding  increased  incidence  of   atherosclerosis,  co ronar y  
heart  diseases,  stroke,diabetes  mellitus,  p re -term  low birth  weight   
deliver y  and   respiratory  d iseases .(Mealey BL 1999) 75 .   
      Recent ly,the relat ionship between periodontit is and   cardiovascular  
diseases is gett ing  much  attent ion  particularly  towards  the   role  of  
putative periodontal pathogens like,P.gingivalis,A.actinomycetemcomitans. 
 Either local inflammatory stimuli (leaking from infected periodontal tissues into 
circulation) or systemic inflammatory stimuli (resulting from immune responses to 
periodontitis-associated bacteremia) can induce activation of endothelial cells and/or 
platelets. Furthermore, direct interaction between pathogens and endothelial cells 
and/or platelets might contribute to the development of cardiovascular disease (Li L, 
Messas E,2002.)65 
Platelet activation has been implicated in the pathogenesis of a number of 
diseases, which including atherosclerosis, coronary vascular disease, and 
cerebrovascular disease(Cahill MR,1993)23. Abnormal platelet activation has also 
been associated with atrial fibrillation  (Minamino,1999) 78, cancer, peripheral 
vascular disease, Alzheimer disease  (Sevush S,1998)101 , inflammatory bowel 
disorders  (Collins CE,1994)25 and deep vein thrombosis (De Boer AC,1981)30 . 
Platelet activation seems to be influenced by diabetes mellitus, smoking ,hypertension 
and also the use of oral contraceptives (Kamath.S  2001 ). 94 
 
  Platelet activation comprises a change in platelet shape, platelet aggregation 
and the release of platelet constituents. According to Kamath.S 200194 , no single test 
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for the quantification of platelet  activation is perfect and each has its own merits  and  
demerits.  
In the present  study, platelet  activation was evaluated by two methods. A  
quant itat ive  analysis  was done in  order to  estimate  the    serum sP –
select in  level by ELISA  method   and  a qualitative   analysis  was  
done   to  evaluate   the  morphological   changes  and  aggregat ion  
pattern of  plate lets by  spreading   analysis  test using  light   
microscopy in  both study  and   control  group.  
All the   subjects   were tho roughly examined and  med ical  
history  was  recorded. Sub jects  with  systemic diseases  like  Diabetes  
mellitus,   hypertension,  card iovascular d isease,  stroke,   systemic  lupus  
erythematous ,    and    hab its  l ike smoking, tobacco, cocaine abuse   
were excluded.(Blann 1997)1 1 
Subjects   under   medicat ions  like Asp irin,  NSAIDS,  
Ticlop idine,  Clopidogrel,  Moxalactam, Losartan,  Procaine,  Dibucaine,  
Mithram ycin,  Diphenhydramine,  Chlo rpheniramine  were exc luded  as  
the y  cause  impairment  o f   p latelet  aggregat ion.  (Anjali& Shaprio et  
al 2008).3  
Also subjects  with  histor y  of trauma or  tooth  extract ion  2  
weeks   prior  to the  study and pregnant  women were  excluded  from 
the  study.  
For   blood sample  collect ion,  20G  needle  was  used  .  Because 
the use  of needle with  narrow diameter may act ivate  the platelets due 
to shear  stress aga inst its  wall.  
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Fast ing venous blood  sample  was co llected  from both stud y  
and  control  groups because  some of the food contents  may act ivate  
platelets.  Foods like Omega-3 fatty acids, fish oil , onion, cumin, turmeric, clove   
decrease platelet thromboxane production  thereby may inhibit the platelet  
aggregation. Vitamin E, onion may  induce inhibition of arachidonic acid metabolism  
and garlic  inhibit  the  fibrinogen binding to platelets  and  impairs  the  platelet  
aggregation.  
In the  present  stud y  the mean  age  group  for control group is 
42.43  years and  for study  group  is  43.20  years.   The mean age  of  
the stud y  and  contro l groups were  similar .(  TABLE III )    
The gender distribution of the study group was Males – 19, Females – 21 and 
control Males – 17 ; Females – 23. In the present study the gender distribution 
between  both the  study  and  control  group was similar. (TABLE IV) 
The Mean PPD value of control group is 2.11mm and of the study group is 
about 4.9mm and the Mean CAL value of study group is 5.8mm (TABLE  V).  
According to AAP classification 1999 the severity of Periodontitis is divided into 3 
groups. 
i) Mild periodontitis  - CAL 1-2mm  
ii) Moderate periodontitis - CAL 3-4mm  
iii) Severe periodontitis - CAL > 5mm  
An  elevated WBC count(reactive leucoc ytosis)  in whole  blood analysis 
was observed among the study group( 8.04± 1.84) in contrast to the control group 




Fredriksson 1998 37 & Loos et al 2000 68  found significantly higher leukocyte 
count in  patients with periodontitis. The leukocyte count has been demonstrated in 
several epidemiological studies to be an independent predictor of future coronary 
heart diseases . 
Considering the differential blood  count , the  neutrophil  count  is  higher  in  
study  group (control 2.94 ± 0.68 & study group 4.09 ± 1.50  ) . Lymphocyte count  is 
elevated  (control 1.95 ± 0.55  & study group 2.83 ± 0.72 ) among the study group and 
is   found to be statistically significant (P<0.001) (TABLES  VII & FIGURE II) 
  Also  data reveals an elevated RBC count  (control 3.99 ± 0.58  study group 
4.41 ± 0.51 )  with P-value 0.001 and Hb% (control 11.43 ± 1.32 gm % study group 
12.20 ± 1.87 gm% with P-value 0.035) among the study group which is statistically 
significant. 
 Reactive   thrombocytosis  was  observed   in   study  group  compared  to  
control group. The  mean  Platelet count in  the study  group was  281.25 ± 84.5 and 
in the control group 200.98 ± 56.9  which  is  found to be statistically  highly 
significant (P=<0.001). This finding concurs with study of  Wakai et al 1999 111who 
stated significant association between platelet counts  and periodontitis and systemic 
inflammation causes  an increase in the number of platelets and platelet 
activation.(Klinger 2002.)63 
Most stimuli cause  changes  in shape of platelets. This change involves first 
the formation of very fine (0.1 µm diameter) pseudopodia (i.e., filopodia) from the 
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rim of the disc, followed by a general "rounding up" of the platelet so that it becomes 
a spiny sphere, often with much broader  pseudopodia.( Nachmlas VT.1983)81 
The fine filopodia are formed of tight  bundles of actin filaments when they 
are demembranated with nonionic detergent and examined by negative staining. 
According  to Nachmlas VT,1977  80 when decorated with heavy meromyosin, they 
develop the well known "arrowheads" that point toward the cell body . This finding 
suggests that the filopodia are probably not "slid out" from the platelet by interacting 
with myosin, which would require the opposite polarity. 
The second step in shape change is the change from a disc into an irregular 
sphere, is correlated with the phosphorylation of platelet myosin( Daniel JL, 1984)29.  
When platelets spread on surfaces, they first put out short filopodia and then the 
cytoplasm fills the space between them with what appears to be a network of actin 
filaments. Change in shape with or without secretion causes the microtubule bundle 
that lies beneath the rim of   the disk to become centralized and surround the platelet 
granules, which are consequently concentrated toward the center of the platelet            
( White JG.1974). 114 
Platelet shape change can be measured in vitro under conditions that probably 
mimic in vivo platelet shape change by flow cytometry or electron microscopy            
( Holmsen H.1994)50. Shape change is seen in an aggregometer tracing as a decrease 
in light transmission and loss of the oscillation. If aggregation follows, this decrease is 
succeeded by increased light transmission.   
    In the present study  the  platelet shape  changes   are   evaluated  by light  
microscopy using oil immersion  objective with  magnification  of  X 100  using  
plastic  slides  instead  of  glass slides. Because glass  slides activate platelets  in vitro 
(Salzman 1963).96  The morphological changes of platelets  in light microscopy is 
65 
 
followed as per the  classification given by Scharrer 1985.97 Among the five types 3 
forms like small, big & spider  forms   are more  prevalent and   other  forms was  
very  rare .  So in  present study  small, big, &  spider forms were considered for 
percentage calculation. 
Small forms were higher in control group  is about 75.83%   compared to  the  
study group 39.08 % . There  was  no  significant difference  in  the big forms  
between the study  and  control  group.    Study   group  showed   a higher  percentage   
of spider forms (59.32%)  while in the   control  group it  is  23.88% . The observation 
showed  high  statistical   significance with  P- value  <0.001  for  small  and  spider  
forms and  no  statistical significance  for the   big  forms P =0.075. Spider form is 
considered  as  a activated  form  of  platelets. This  indicates that  platelet activation 
is  higher   among  the   study group  compared  to  the control  group.(TABLE X & 
FIGURE VI and VII : Photograph  No. 15,16,17) 
Higher  percentage  value of   spider  forms in  study  group  may  infer  that  
stimulation  of  platelets  due  to  the   persistent  periodontal bacterial toxins   causes  
activation  of  platelets and  their  shape  changes . Compared  to   electron  
microscope, light microscope do not faithfully register local differences in their 
thickness,  but do accurately  show changes in their length and orientation. . 
 Several studies have demonstrated that putative periodontal pathogen                  
P. Gingivalis can activate blood platelets and induce platelets aggregation using 
platelet aggregometry  method.  Gingipains (Rgp and Kgp) from P. Gingivalis was 
able to induce platelets aggregation (Curtis 1993)27 and this result is in  agreement 
with Sharma  et al 2000 102 that P. Gingivalis vesicles posses potent platelet 
aggregation activity due to active concentration of many virulence factors. 
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P. gingivalis-induced platelet aggregation in platelet rich plasma (PRP) depends 
on hemagglutinin A (HagA)-encoding genes that intragenically code for adhesions, 
such as hemagglutinin domain proteins Hgp44, but not Arg-gingipain (Rgp) 
proteinase.   (Naito 2006) 82. 
Keber 1979 61   evaluated the  anti- aggregating property  of  propananol based on  
Breddin 1965 14classification  on  platelet  aggregation. The  present study is also  
according to  the  classification given by  Breddin 196514 light  microscopy. 
Observation revealed , Grade I  & II  aggregation patterns   were  more  in control 
group whereas  Grade III  pattern was higher in   the study group . Grade IV   
aggregation is  seen only  in the  study   group. None of the group showed grade V 
aggregation pattern. (TABLES  XI & FIGURE  VIII)  
According to   Breddin’s 14classification grade I & grade II  is  considered as a 
physiological aggregation(reversible  aggregation)  and grade III & IV is considered 
as a pathological aggregation Irreversible  aggregation) (See photograph No.18- 21) 
Result of the present study showed higher percentage prevalence  for pathological 
aggregation in  the study group (grade III 67.5% grade IV 5%)  compared to the 
control group (grade III 12.5 % and grade IV 0%).  
The   limitations  of  spreading  analysis  test  is that it cannot define  the   
aggregation size   like platelet  aggregometry . In platelet  aggregometry ,  the  
aggregation  can  be classified as  small (diameter 9-25 µm), medium (diameter 26-50 
µm), and large-sized aggregates (diameter >50 µm) based  on  their  size  (Ozaki Y, 
1994) 86.  However  spreading  analysis  test  shows  the  grade  of platelet aggregation   
and  helps us  to   decide  the  pathological   aggregation . 
Several  studies  have  proved that act ivated   plate lets  expressed   
increased p-select in   leve l  which  has  a vital  role   in  
67 
 
atherosclerotic les ion  develo pment . (  Burger Peter C 2003)2 1 . Raised 
levels of soluble P-selectin are found in a variety of thrombotic disorders, including 
ischaemic heart disease (Ikeda H,1994)51 , cerebrovascular disease, congestive 
cardiac failure (O’Connor CM,1999)84 , and  hypertension .(Lip GYH, 1995)66  
Measurement of plasma levels of beta thromboglobulin and Platelet Factor 4 
are specific to platelet release  (Schernthaner G,1979) 98 and has been suggested as a 
means for detecting increased platelet activation in-vivo (Kaplan KL,1981) 59. 
However some problems are evident with respect to measurement of these proteins. 
Thromboglobulin and Platelet Factor 4 are theoretically present in platelets in similar 
amounts and are released in similar quantities, but plasma levels of beta 
thromboglobulin greatly exceed plasma levels of Platelet Factor 4. This is possibly 
due to the  more rapid binding of Platelet Factor 4 to the endothelial cells .Therefore a 
higher ratio of beta thromboglobulin to Platelet Factor 4 is always maintained in vivo. 
(Kaplan KL1981)59. Due to above mentioned  limitations we  have P-selectin.. 
 Moreover ,  activat ion o f  -granules  need  higher threshold  
va lue  compared    to   GPIIb/IIIa which  need  lower  thershold  va lue.  
(Michael .B.Holmes 1999) 7 6    and   hence the  influence of extraneous  
factors  l ike speed  of centrifugat ion ,  temperature  can be eliminated.  
Michelson et al 1999 77 study showed that activated platelets shed their membrane 
bound P-selectin in the plasma.   Papapannagiotou et  al 2009 88  was the  first  to 
document increased plasma levels of sP-selectin in chronic periodontitis. Result of  
the study showed that sP-selectin was statistically highly significant when compared 
with control group  and positively associated with severity of periodontitis. According  
to  this   study increased   level of P-selectin expression is from platelets and  not  
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from endothelium, as vWf ( marker  of  endothelial activation)  was normal in their  
study.  
Assinger.A 2010 4 (Unpublished  data) also  documented the  increased  level  of               
P-selectin associated  with   periodontitis  and  correlated  with the severity  of the  
disease. According   to  this  study both platelets  and endothelial cells seem to be 
responsible for the observed increased in plasma levels of soluble P-selectin in 
periodontitis. However,  since platelet derived P-selectin is identical to   P- selectin 
derived  from  endothelial cells ,the  cell  type  specific  contribution  was  not  
known. 
In our  study,  sP-selectin  expression  is significantly  higher  in the  study group 
when compared with control. The mean value for control group is 4.97 ± 16.56 ng/ml 
and study group is 13.05 ± 29.94 ng/ml is  found to be highly significant (P<0.001) 
.(TABLE VIII  &  FIGURE  IV) 
   Level of  P-selectin  expression is   higher  in  severe  periodontitis (CAL 
>5mm) compared  to moderate  periodontitis ( CAL< 5mm).(TABLE IX & FIGURE 
V) Results  of  this study  concurs with the reports of  Papapannagiotou 200988 and 
Assinger.A 2010 4.  However we  have  not  evaluated  the  source of   P-selectin 
In the  present study, 3  of the  healthy  controls had elevated soluble P-selectin 
levels  even  when  their pocket depth was ≤2 mm. Assinger.A 2010 4 also 
documented  similar findings in  his  control  group  and revealed the presence of 
A.actinomycetemcomitans Y4 or P. gingivalis among those  controls.   
The  influence  of P-selectin   on  platelet  aggregation was  correlated with  
Pearson’s  correlation coefficient test which showed  a  positive  correlation (P- value 
= 0.005). (TABLE XII &FIGURE IX). According  to  Micheal et al  199976 P-selectin 
determines the size and stability of platelet aggregation. P-selectin, which is 
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progressively expressed on the platelet surface, binds by means of the lectin domain 
to its binding site on adjacent platelets, stabilizing interactions between already-
bridged platelets, thereby allowing the formation of large stable platelet aggregates.    
( Boukerche H 1996)13 
Moreover ,  the  role  of  P-Selectin  in  atherosclerotic lesion  development  is  
very  important. According  to  Rinder 1991 93, P-selectin expressed by platelet 
activation causes the  formation of platelet-neutrophil  and platelet-monocyte  
aggregates in blood  . Berger P.  C. 2003 21   states  that  P-selectin on microparticles 
could coat monocytes and contribute to their recruitment into atherosclerotic  lesions. 
Study done  in  P-selectin deficient mice have proved that both atheroselerotic 
lesion formation (Johnson RC 1997 56, Collins RG 2000)26 and neointimal growth 
upon arterial injury  were attenuated in apoE (apoE-/-) & LDL –receptor (LDLR-/-) 
deficient mice.  
In the present   study , both  quantitative (estimation of  serum P- selectin 
level) and qualitative  analysis( morphological  changes and  pathological aggregation 
pattern )  findings  are positively correlated  with  chronic  periodontitis  and their 
disease  severity.  Thereby   we  infer  that  periodontitis  associated   with  platelet  








 SUMMARY & CONCLUSION 
Eighty subject were included in this study. The subject were catergorized into 
two groups. Cases (n=40) and controls (n=40). Thorough history was taken  and the 
periodontal parameters like plaque index, bleeding index, probing depth, CAL were 
recorded. Blood samples were collected and  platelet activation   assessed   by 
estimation of serum sP-selectin level by ELISA method and morphological changes 
of platelets and their aggregation pattern were evaluated by spreading analysis test 
using light microscopy. 
The results of the study showed ,higher number of spider  forms  and 
significant   pathological   aggregation  pattern   in  study  group which indicates   
activation   of  platelets  . An elevated serum sP-selectin level was  seen  in  
periotontitis patients compared to the control. Also sP-selectin expression increased  
in severe  periodontitis than moderate periodontitis. Number of platelets, total WBC, 
lymphocytes, neutrophils, were  increased  in study group than  control  group. 
The higher incidence of bacteremias and intravascular dissemination of 
bacterial products and inflammatory cytokines in periodontitis subjects could 
possibily provide an explanation for the current findings.( Forner L, 2006)36 . These 
products have the potential to activate platelets which in turn can release an arsenal of 
potent inflammatory and mitogenic substances leading to an altered endothelial 
function (chemotaxis and adhesion). Thus a procoagulant state is established which 
provides a possible explanation for the increased risk for coronary heart disease in 
periodontitis subjects compared to controls as proved by epidemiological observation 
of Janket SJ 2003 53. 
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Chronic periodontitis induces systemic inflammation which ultimately leads to 
activation of platelets and translocation of sP-selectin from α – granules. This might 
be a cause for the morphological changes of platelets and occurrence of the increased 
percentage of activated form (spider form) .The pathological aggregation of platelets 
demonstrated in chronic periodontitis patients could be possibly due  to elevated 
serum sP-selectin level induced  by systemic inflammation.   
Platelets play a central role in the process of thrombus formation 
(thrombogenesis) ( Hoak JC.1988)  47, as well as an important role in atherogenesis    
( Rabbani LE, 1994) 92 and the progression of atherosclerotic lesions. The interaction 
of the platelet with the vessel wall and its subsequent contribution to atheroma 
formation and thrombosis is of pivotal importance in the aetiology and pathogenesis 
of peripheral, coronary, cerebrovascular and other vascular diseases  (White JG 
1994).114 
Results  of  the present  study  shows an  increased  expression  of P-selectin , 
spider  form of  platelets and pathological aggregation   pattern   which  indicates that 
platelet  activation may be associated with   chronic periodontitis  though the  exact  
mechanism  could  not  be  established . Chronic  periodontitis  leads  to  platelet  
activation it  may  be emphasized  that   periodontitis can  be an contributing  factor  
in the  development  of  cardiovascular  disease .   
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              APPENDIX  
    PROFORMA 
EVALUATION  OF  PLATELET  ACTIVATION  BY  ESTIMATING  SERUM        
sP-SELECTIN   LEVEL  AND  MORPHOLOGICAL  CHANGES  OF  PLATELETS 
IN PERIODONTAL  HEALTH  AND DISEASE. 
             
Name  :     Age / Sex : 
 
O.P. No             :                  Code No  : 
 
Occupation :     Income    : 
 




Pain / Shaky teeth / Bleeding gums / Swollen Gums / Receding Gums / Pus Discharge / 





1. Trauma or  tooth  extraction 
2. Patients  drug  history(  antibiotics, anticoagulants) 
3. Any  chronic   infectious diseases 
4. Pregnancy  
5. Anemia, bleeding disorders or any other hematological disorder  






     Periodontal treatment within past 6 months. 
Clinical Examination                                                                            
   GINGIVAL BLEEDING INDEX – AINAMO & BAY (1975) 
 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
  PLAQUE INDEX – SILNESS & LOE (1964) 
 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
 
PROBING DEPTH (PD) & CLINICAL ATTACHMENT LEVEL (CAL) (in mm) 
MAXILLARY:    
     Palatal 
CAL                 
PPD                 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
PPD                 
CAL                 








     Lingual 
CAL                 
PPD                 
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
PPD                 
CAL                 









      Morphological changes         -  small = 
                                                                   -   Big  = 
                                                                   -  spider = 
                  Platelet  aggregation              - 
                  sP- Selectin                              - 







 INFORMED CONSENT FORM  
STUDY TITLE: 
EVALUATION  OF  PLATELET  ACTIVATION  BY  ESTIMATING  SERUM  sP-
SELECTIN   LEVEL  AND  MORPHOLOGICAL  CHANGES  OF  PLATELETS IN 
PERIODONTAL  HEALTH  AND DISEASE. 
 
Name:        O.P.No: 
Address:                  Code No: 
                                                                                                        Tel. no: 
I,___________________________________________________age____years exercising my 
free power of choice, hereby give my consent to be included as a participant in the study 
“Evaluation  of  platelet  activation  by  estimating  serum  sP-selectin  level  and  
morphological  changes  of  platelets in periodontal  health  and disease” 
 
I agree to the following: 
 
 I have been informed to my satisfaction about the purpose of the study and study 
procedures including investigations to monitor and safeguard my body function. 
 I understand that the lab investigations will require the procurement of my blood in 
required amount. 
 I agree to cooperate fully and to inform my doctor immediately if I suffer any 
unusual symptom. 
 I have informed the doctor about all medications I have taken in the recent past and 
those I am currently taking. 
 I hereby give permission to use my medical records for research purpose. I am told 
that the investigating doctor and institution will keep my identity confidential. 
 
        Name of the patient   Signature / Thumb impression  
 





      
 
